Patents Assigned to College
  • Patent number: 11337744
    Abstract: A system and method for installation of a k-wire through a scaphoid or other fractured bone can include a guide block for accurate trajectory of a k-wire. A support frame for a guide block can be casted and/or secured into place, and a CT scan is obtained, so the fractured bone and the location of the window can be known in the same three-dimensional space. An ideal k-wire trajectory can be plotted through the fractured bone, and a guide block with a lumen can be designed and printed using a three-dimensional printer. The guide block can be inserted into the frame so the lumen aligns with the ideal k-wire trajectory, and a k-wire can be inserted through the lumen into the fractured bone. The net effect would be ideal placement of the k-wire that would facilitate the ultimate insertion of a percutaneous screw to provide fixation of the fractured bone.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: May 24, 2022
    Assignee: Dartmouth-Hitchcock Clinic and The Trustees of Dartmouth College
    Inventors: Matthew C. DeWolf, Alexander Hartov, Lance G. Warhold
  • Patent number: 11339204
    Abstract: The present invention relates to novel truncated fragments of von Willebrand factor (VWF) and the use of such fragments and nucleic acids encoding such fragments in the treatment of von Willebrand disease (VWD) and haemophilia.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: May 24, 2022
    Assignee: Imperial College Innovations Ltd.
    Inventors: Thomas McKinnon, Mike Laffan
  • Patent number: 11339201
    Abstract: The present disclosure provides variant PD-L1 immunomodulatory polypeptides, and fusion polypeptides comprising the variant immunomodulatory peptides. The present disclosure provides T-cell modulatory multimeric polypeptides, and compositions comprising same, where the T-cell modulatory multimeric polypeptides comprise a variant immunomodulatory polypeptide of the present disclosure. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the T-cell modulatory multimeric polypeptides, and host cells comprising the nucleic acids. The present disclosure provides methods of modulating the activity of a T cell; the methods comprise contacting the T cell with a T-cell modulatory multimeric polypeptide of the present disclosure.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 24, 2022
    Assignee: Albert Einstein College of Medicine
    Inventors: Sarah C. Garrett-Thomson, Steven C. Almo, Ronald D. Seidel, III
  • Patent number: 11337432
    Abstract: A vision guided intelligent system for automated crab meat picking operates in a fully automated or semi-automatic modes of operation using a crab meat picking routine based on (a) the CNN model localization of back-fin knuckles algorithm, and/or (b) the Deep Learning model which accurately locates not only knuckle positions, but also crab legs and crab cores, with a high pixel accuracy (up to 0.9843), and low computation time. The subject system uses a concept of analyzing crab morphologies obtained from digital crab images, and, using a Deep Learning architecture integrated in the system, segments crab images into five regions of interest in a single step with high accuracy and efficiency. The image segmentation results are used for generating crab cut lines in XYZ and angular directions, determining starting cutting points in Z plane, and guiding cutting tools and end effectors to automatically cut crabs and harvest crab meat.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: May 24, 2022
    Assignee: University of Maryland, College Park
    Inventors: Yang Tao, Robert Vinson, Dongyi Wang, Maxwell Holmes, Gary E. Seibel
  • Patent number: 11340227
    Abstract: The invention includes, in part, methods and compounds for diagnosing diseases and conditions characterized by altered threonyl-tRNA synthetase (TARS) activity, which include, but are not limited to diseases and conditions in which angiogenesis is altered. In some embodiments of the invention, a level of a TARS molecule is determined and compared to a control level of TARS to assess onset, progression, and/or regression of a disease or condition associated with altered TARS activity.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 24, 2022
    Assignee: University of Vermont and State Agricultural College
    Inventors: Christopher Francklyn, Karen M. Lounsbury, Tamara Williams
  • Patent number: 11339396
    Abstract: Modified viral genomes are able to reduce induction of inflammatory and immune anti-viral responses. This manifests itself in reduced NF-kB activity, increased viral transduction rates, and increased expression of transgenes. Viral genomes are modified by incorporating one or more oligonucleotide sequences which are able to bind to TLR9 but not induce activation of it. The oligonucleotide sequences may be synthetic, bacterial, human, or from any other source.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: May 24, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Ying Kai Chan, George M. Church
  • Patent number: 11339378
    Abstract: Provided herein are compositions and methods for vaccination and research applications. In particular, provided herein are non-neuroinvasive herpesviruses and alpha herpesviruses and uses thereof.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: May 24, 2022
    Assignees: Northwestern University, Board of Regents of the University of Nebraska, Trustees of Tufts College
    Inventors: Gregory A. Smith, Patricia Jane Sollars, Gary Edward Pickard, Ekaterina E. Heldwein
  • Publication number: 20220154310
    Abstract: The present disclosure provides stable elastocaloric cooling materials and methods for producing and using the same. Elastocaloric cooling materials of the present disclosure are capable of withstanding 106 cycles. In some embodiments, elastocaloric cooling materials of the present disclosure comprise a mixture of a transforming alloy and a non-transforming intermetallic phase at a ratio of from about 30-70% transforming alloy to about 70%-30% of non-transforming intermetallic phase.
    Type: Application
    Filed: November 15, 2021
    Publication date: May 19, 2022
    Applicants: University of Maryland, College Park, Iowa State University Research Foundation, Colorado School of Mines, The Government of the United States as Represented by the Secretary, Department of Energy, Ames Labo
    Inventors: Ichiro TAKEUCHI, Jun CUI, Huilong HOU, Valery I. LEVITAS, Ryan T. OTT, Aaron P. STEBNER
  • Publication number: 20220154237
    Abstract: The disclosure provides amino acid sequence variants of orthogonal aminoacyl-tRNA synthetases (AARSs) having increased activity and selectivity compared to previous AARSs, and methods of producing the same.
    Type: Application
    Filed: July 3, 2018
    Publication date: May 19, 2022
    Applicant: President and Fellows of Harvard College
    Inventors: David R. Liu, David Irby Bryson, JR.
  • Publication number: 20220153620
    Abstract: Taught herein is a two stage process for removing dissolved and emulsified oil from produced water (PW) from, for example, a hydrocarbon well. The first stage involves microbiological stimulation of indigenous oil degrading methanogenic microbial communities that are adapted to high salinity conditions preferably by supplying carbon dioxide and protein-rich matter (isolated soy protein) under controlled pH conditions. The second stage removes toxic metals using filters made of compressed powdered dolomite of uniform grain size. Increased levels of toxic metals removal are achieved by filtrating PW previously treated for oil. To further increase the removal efficiency of the dolomite filter, calcium and magnesium is removed from PW by the addition of lime and soda ash in a sedimentation tank, and guar gum is supplied to PW to enable the trapping of toxic metals by guar gum in small pore throats of the dolomite filter.
    Type: Application
    Filed: November 15, 2021
    Publication date: May 19, 2022
    Applicant: The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
    Inventor: JAVIER VILCAEZ
  • Patent number: 11332783
    Abstract: The present invention provides a combination of genomic and computational technologies to provide rapid, portable sample analysis for sequencing or identifying a target sequence involving generating probes for use in analyzing a sample which may comprise a target sequence.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: May 17, 2022
    Assignees: The Broad Institute, Inc., Massachusetts Institute of Technology, President and Fellows of Harvard College
    Inventors: Hayden Metsky, Andreas Gnirke, Christian Matranga, Daniel Park, Pardis Sabeti
  • Patent number: 11332565
    Abstract: A UV-curable and recyclable thermoset shape memory polymer is provided. The polymer includes a vitrimer-based monomer and a photoinitiator. The vitrimer-based monomer includes a first unit rendering a high chain stiffness upon polymerization of the monomer, and a second photopolymerizable unit for photopolymerization of the monomer under a UV irradiation. The polymer has high strength, high stiffness, high recovery stress, high energy storage, reasonable recycling efficiency, and is printable using SLA with high resolution.
    Type: Grant
    Filed: April 30, 2019
    Date of Patent: May 17, 2022
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Ang Li, Guoqiang Li
  • Patent number: 11333668
    Abstract: Methods for the large scale identification of post-translational modification states of proteins and enzyme activities for carrying out post-translational modification reactions involve the analysis of functional extracts from fresh and frozen samples using protein arrays. The methods and kits of the present invention can be used to analyze and characterize compounds for their effects on post-translational modifications and their pathways. The methods and kits can also be used to diagnose and characterize a wide variety of diseases and medical conditions, including cancer, neurodegenerative diseases, immune diseases, infectious diseases, genetic diseases, metabolic conditions, and drug effects using cells or body fluids of a patient.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: May 17, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Yifat Merbl, Marc W. Kirschner
  • Patent number: 11332496
    Abstract: The present invention provides stapled polypeptides of the Formulae (I) and (VI): and salts thereof; wherein the groups ; R1a, R1b, R1c, R2a, R3a, R2b, R3b, R4a, R4b, RA, RZ, L1a, L1b, L2, L3, XAA, v, w, p, m, s, n, t, and q are as defined herein. The present invention further provides methods of preparing the inventive stapled polypeptides from unstapled polypeptide precursors. The present invention further provides pharmaceutical compositions comprising a stapled polypeptide of Formula (I) or (VI), and methods of using the stapled peptides. The present invention also provides modifications of the staples post ring closing metathesis.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: May 17, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: Gregory L. Verdine, Gerard Hilinski
  • Patent number: 11332426
    Abstract: Method of forming a trisubstituted ethylene compound, the method comprising: (A) providing a trisubstituted ethylene compound bearing a first, a second and a third substituent, in which the first and the second substituent are bound to the one olefinic carbon atom and are different from one another; (B) providing a monosubstituted ethylene compound or a disubstituted ethylene compound in which the substituents are vicinally bound to the olefinic carbon atoms, bearing at least a fourth substituent, respectively; (C) subjecting the trisubstituted ethylene compound provided in step (A) to a cross-metathesis reaction with olefin provided in step (B) to form said trisubstituted ethylene, wherein the cross-metathesis reaction is catalysed by a transition metal complex bearing ligands from which one ligand is a carbene ligand, wherein the carbene complex is characterized by a M=C moiety, wherein M is the transition metal; and wherein the reaction proceeds stereoselectively.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: May 17, 2022
    Assignees: Trustees of Boston College, Massachusetts Institute of Technology
    Inventors: Amir H. Hoveyda, Thach T. Nguyen, Ming Joo Koh, Chaofan Xu, Sebastian Torker, Richard Royce Schrock
  • Patent number: 11331492
    Abstract: Methods and apparatus are disclosed relating to the stimulating of tissue including nerve tissue based on combinations of capacitors and resistors. Application and removal of voltage to an electrical circuit is taught as part of a method of creating voltage waveforms for nerve and other tissue with such waveforms creating neural signals. The electrical apparatus taught may, include a first electrical node grounded through a first resistor; a second electrical node grounded through a second resistor; a first capacitor connected to both the first electrical node and the second electrical node; a second capacitor separating the second electrical node from a biological grounding point and direct current sources connected to the two nodes.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: May 17, 2022
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jose A. Parodi Amaya, Edward F Austin, Jin-Woo Choi
  • Patent number: 11331033
    Abstract: Apparatus for monitoring activation in a heart comprises a probe 101, a plurality of electrodes 102 supported on the probe and extending over a detection area of the probe, the detection area being arranged to contact a detection region of the heart. Each of the electrodes 102 is arranged to detect electrical potential at a respective position in the heart during movement of a series of activation wave fronts across the detection region. A processor is arranged to analyse the detected electrical potentials to identify a propagation direction of at least one of the wave fronts, and to generate an output indicative of that direction.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: May 17, 2022
    Assignee: Imperial College of Science, Technology and Medicine
    Inventors: Prapa Kanagaratnam, Nick Linton, Darrel Francis
  • Publication number: 20220142947
    Abstract: A transdermal formulation for the delivery of a nitric oxide booster or nitric oxide precursor to a subject is provided. The formulation can be applied to the treatment of various diseases or conditions by enhancing systemic level of nitric oxide.
    Type: Application
    Filed: December 30, 2021
    Publication date: May 12, 2022
    Applicant: Albert Einstein College of Medicine
    Inventor: Joel M. Friedman
  • Publication number: 20220142913
    Abstract: A transdermal formulation for the delivery of a nitric oxide booster or nitric oxide precursor to a subject is provided. The formulation can be applied to the treatment of various diseases or conditions by enhancing systemic level of nitric oxide.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Applicant: Albert Einstein College of Medicine
    Inventor: Joel M. Friedman
  • Publication number: 20220145391
    Abstract: This invention relates to methods and compositions for assessing amount(s) of total cell-free DNA in a subject. Such amount(s) can be used to determine risk in a subject, which subjects are non-transplant subjects, such as surgical subjects, in some preferred embodiments.
    Type: Application
    Filed: June 16, 2021
    Publication date: May 12, 2022
    Applicant: The Medical College of Wisconsin, Inc.
    Inventors: Aoy Tomita Mitchell, Michael Mitchell